141 Hits in 0.69 sec

Can technology conquer biology in craniofacial surgery for malignant tumors

Jatin P. Shah
2014 Journal of Oral Biology and Craniofacial Research  
Jatin P.  ...  Shah Professor of Surgery, E W Srong Chair in Head and Neck Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA E-mail address: shahj@MSKCC.ORG 2212-4268/$ e see front matter Copyright  ... 
doi:10.1016/j.jobcr.2013.05.001 pmid:25737909 pmcid:PMC4252632 fatcat:vca7jznnvfc5fce27zt5qe6hwe

Estadios precoces de cancer oral: pronóstico en relación con gradación histológica, linfagiogénesis intratumoral y expresión de factor de crecimiento endotelial vascular Tipo-C (VEGF-C)

Jatin P. Shah
2006 Revista Española de Cirugía Oral y Maxilofacial  
Jatin P. Shah Bibliografía Jefe de Servicio. Servicio de Cirugía de Cabeza y Cuello Memorial Sloan-Kettering Cancer Centrer. New York, EE.UU.  ... 
doi:10.4321/s1130-05582006000100003 fatcat:bsi2juijqjhqdh4jgnhkz4a3qe

Thyroid carcinoma: epidemiology, histology, and diagnosis

Jatin P Shah
2015 Clinical advances in hematology & oncology : HO  
Shah Page 10  ... 
pmid:26430868 pmcid:PMC5526593 fatcat:vnmbq2obdjcbzljrdym3bohz3m

Potency Paradox and Homoeopathy

H ahnemann, the founder of Homoeopathy in many places of his vast literature has given full credit to Hippocrates or a discover of law of similia, Vital force, Single medicine but the Law of minimum dose was solely his invention. In available Hippocratic Cannon we cannot find any place for minimum dose though Hahnemann himself writes that this conception he also had borrowed from the Father of Medicine. Being a lifetime inquisitive student he had gone through the relevant literature available
more » ... erature available to his time, made this theories and postulations upto date and then came to the conclusion. The basic difference lies between drugs and poisons is in its quantity was known to Hahnemann but his search continued to understand what should be the parameter to determine the quantity. As we all know that Hahnemann had started practicing with almost the same drugs used in daily practice of the Galenians. Only the law of similia was minutely maintained. Here we must keep in mind that the word potency varies at a long distance to the dose, but how we would like to be with R. E. Dudgeon. He says, "It is impossible so to separate the dynamization (potehnization) theory from the doctrines
doi:10.15740/has/ijms/9.1/50-61 fatcat:yjzzpqoovbhybffhewgjohpqfy

Current concepts in management of oral cancer – Surgery

Jatin P. Shah, Ziv Gil
2009 Oral Oncology  
(From Shah J and Patel S. 4 ) Oral Oncol. Author manuscript; available in PMC 2014 August 12.  ...  (Adapted from Shah JP, Johnson NW, et al. 26 ) Overall survival of patients with advanced stage oral cancer in three different time frames at MSKCC. New York.  ... 
doi:10.1016/j.oraloncology.2008.05.017 pmid:18674952 pmcid:PMC4130348 fatcat:sqnuezjlxrblhimb3pucovz2ja

Risk Adapted Strategies in the Management of Thyroid Cancer

Jatin P. Shah, Cristina Valero Mayor
2020 International Bulletin of Otorhinolaryngology  
Risk group categories (From Jatin Shah's Head and Neck Surgery and Oncology - 5 th edition, Elsevier, 2019) Fig. 5.  ...  ) Disease-specific survival according to nodal status in all patients (A) and stratified by age by age (B) (From Jatin Shah's Head and Neck Surgery and Oncology -5th edition, Elsevier, 2019) .  ... 
doi:10.14748/orl.v16i2.6737 fatcat:5tvoh4j45ze77a7b76biphbakm

Surgical technique refinements in head and neck oncologic surgery

Jeffrey C. Liu, Jatin P. Shah
2010 Journal of Surgical Oncology  
[14] Similar findings were also reported by Shah [15] , who reviewed 1119 RND performed at Memorial Sloan-Kettering Cancer Center.  ... 
doi:10.1002/jso.21454 pmid:20512941 pmcid:PMC2957802 fatcat:k3anle4kqvg6re6jij6lvwss7q

Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and Implications

Daniella Karassawa Zanoni, Snehal G. Patel, Jatin P. Shah
2019 Current Oncology Reports  
JAMA Otolaryngol Head Neck Surg, 2014 140(12): p. 1138-48.  ...  J Clin Oncol, 2011 29(32): p. 4294-301. [PubMed: 21969503] 9.  ... 
doi:10.1007/s11912-019-0799-x pmid:30997577 pmcid:PMC6528815 fatcat:ejscio6km5cihlcar2swm4l3we

Poorly differentiated carcinoma of the thyroid gland: Current status and future prospects

Tihana Ibrahimpasic, Ronald Ghossein, Jatin P Shah, Ian Ganly
2019 Thyroid  
Introduction P oorly differentiated thyroid carcinoma (PDTC) is a rare type of thyroid cancer, with a reported incidence from 2% to 15% of all thyroid cancers (1) .  ... 
doi:10.1089/thy.2018.0509 pmid:30747050 pmcid:PMC6437626 fatcat:3mgczmapvva7hl35t52wqvdoqa

Malignant tumors of the skull base

Jatin P. Shah, Mark H. Bilsky, Snehal G. Patel
2002 Neurosurgical Focus  
doi:10.3171/foc.2002.13.4.7 pmid:15771405 fatcat:zcen46ucfba6vpfpnumtdqjgva

High rates of regional failure in squamous cell carcinoma of the hard palate and maxillary alveolus

Luc G. T. Morris, Snehal G. Patel, Jatin P. Shah, Ian Ganly
2010 Head and Neck  
Evans and Shah, 8 in 1981, reviewed 252 cases of SCC of the palate, of which 62 were hard palate tumors. Cervical metastases were present in 29% of hard palate tumors at presentation.  ...  Comparing rates of neck metastasis at presentation and at recurrence, there was no difference in N classification (p = .55) or in neck levels involved (p = .60).  ... 
doi:10.1002/hed.21547 pmid:20949448 pmcid:PMC3061243 fatcat:234ewwcqgbfttobkn4jtkgrakq

Squamous Cell Carcinoma of the Oral Tongue in the Pediatric Age Group

Luc G. T. Morris, Snehal G. Patel, Jatin P. Shah, Ian Ganly
2010 Archives of Otolaryngology - Head and Neck Surgery  
The 5-year DSS was also equivalent: 80% in the pediatric group and 76% in the adult group (P=.90). The 5-year RFS was 70% in the pediatric group and 78% in the adult group (P =.54).  ...  Results: The 5-year OS was equivalent in the 2 groups: 70% in the pediatric group and 64% in the adult group (P=.97).  ...  The absolute risk differences in this study of 6% in OS (favoring pediatric patients) (P =.97), 4% in DSS (favoring pediatric patients) (P =.90), and 8.4% in RFS (favoring adult patients) (P =.54) were  ... 
doi:10.1001/archoto.2010.94 pmid:20644066 pmcid:PMC3005582 fatcat:ptgnmew5evh4zhznyiwqw7zpqq

Complications after craniofacial resection for malignant tumors: Are complication trends changing?

Ziv Gil, Snehal G. Patel, Mark Bilsky, Jatin P. Shah, Dennis H. Kraus
2009 Otolaryngology and head and neck surgery  
Complications were identified in 52 percent of the early and 33 percent of the later groups (P ϭ 0.002).  ...  There was 20 percent decrease in wound complications in the later period (P Ͻ 0.0001), but not in other complications.  ...  P.  ... 
doi:10.1016/j.otohns.2008.10.042 pmid:19201292 fatcat:hggvliup4zhjdc7vt4m4yej3xy


Ajay M. Parmar, Kanan P. Shah, Jatin Goda, Brijesh Aghera, G. C. Agarwal
2015 International Journal of Anatomy and Research  
Mukhopadhyay P [4] Sarzoo Desai[6], Sing S[5], Kate and Mazumdar Measurements RIGHT LEFT MFL= 23.03 + 3.50(P1) MFL= 26.03 + 2.71(P2) MFL= 23.71 + 2.93(P2) MFL= 31.54 + 4.05(P3) MFL= 23.67 + 6.23  ... 
doi:10.16965/ijar.2015.310 fatcat:7mppan6znved5gmjlkaypj5uki

Malignant Minor Salivary Gland Tumors of the Larynx

Ian Ganly, Snehal G. Patel, Maria Coleman, Ronald Ghossein, Diane Carlson, Jatin P. Shah
2006 Archives of Otolaryngology - Head and Neck Surgery  
Correspondence: Jatin P. Shah, MD, Head and Neck Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021 ( Financial Disclosure: None reported.  ... 
doi:10.1001/archotol.132.7.767 pmid:16847187 fatcat:6bf2gpvkwbebzaywbhl5gikria
« Previous Showing results 1 — 15 out of 141 results